Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “RSV Respiratory Syncytial Virus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT06775405
What this trial is testing

Confirm the Effectiveness and Safety of AK0529 in Treating RSV Infections in Hospitalized Infants

Who this might be right for
Respiratory Synctial Virus Infections
Shanghai Ark Biopharmaceutical Co., Ltd. 180
Early research (Phase 1)Study completedNCT03227029
What this trial is testing

Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 65
Not applicableNot Yet RecruitingNCT07417657
What this trial is testing

Gut Microbiome and Immune Response in Severe RSV Infection in Vietnamese Infants

Who this might be right for
Respiratory Syncytial Virus InfectionBronchiolitisViral Lower Respiratory Tract Infection (LRTI)
Phuc Huu Phan 250
Early research (Phase 1)Study completedNCT06583031
What this trial is testing

Study to Evaluate the Safety and Immune Response of an Investigational Vaccine for the Prevention of RSV (Respiratory Syncytial Virus) and (hMPV) Human Metapneumovirus Infection in Participants Aged 60 to 75 Years

Who this might be right for
RSV InfectionhMPV
Sanofi Pasteur, a Sanofi Company 385
Not applicableStudy completedNCT02282982
What this trial is testing

Observational Program to Assess Respiratory Syncytial Virus (RSV) Hospitalization Rate in Population of Children at High-risk of Serious RSV Illness Who Received Palivizumab Immunoprophylaxis

Who this might be right for
Respiratory Syncytial Virus (RSV)
AbbVie 359
Testing effectiveness (Phase 2)Study completedNCT03382431
What this trial is testing

PC786 to Evaluate the Antiviral Activity, Safety and Pharmacokinetics of Multiple Doses in an RSV Challenge Study

Who this might be right for
Respiratory Syncytial Virus Infections
Pulmocide Ltd 56
Not applicableActive Not RecruitingNCT03756766
What this trial is testing

Understanding RSV: Severe Disease and the Long Term Consequences

Who this might be right for
Respiratory Syncytial Virus (RSV)
University of Oxford 315
Not applicableEnrolling By InvitationNCT06401720
What this trial is testing

Age Related Differences in Respiratory Immune Responses in Influenza Virus Infection

Who this might be right for
Influenza A InfectionInfluenza B Virus InfectionSARS CoV 2 Infection+1 more
Karolinska Institutet 800
Not applicableStudy completedNCT02618213
What this trial is testing

Comparison of High Flow Oxygenation Therapy and CPAP in Children With Bronchiolitis.

Who this might be right for
Respiratory Syncytial Virus Bronchiolitis
Esbjerg Hospital - University Hospital of Southern Denmark 50
Testing effectiveness (Phase 2)Study completedNCT03691623
What this trial is testing

A Phase 2a Study to Evaluate EDP-938 in the Virus Challenge Model

Who this might be right for
RSV Infection
Enanta Pharmaceuticals, Inc 179
Testing effectiveness (Phase 2)Looking for participantsNCT07050732
What this trial is testing

Immunogenicity of RSVPreF3 Vaccine in Immunocompromised Persons

Who this might be right for
Respiratory Syncytial Virus (RSV)
Johns Hopkins University 170
Testing effectiveness (Phase 2)Study completedNCT02718937
What this trial is testing

Safety, Efficacy and Pharmacokinetics of BTA-C585 in a RSV Viral Challenge Study

Who this might be right for
Respiratory Syncytial Virus (RSV) Infection
Biota Pharma Europe Limited 60
Not applicableEnded earlyNCT03909867
What this trial is testing

Emission Patterns of Respiratory Syncytial Virus

Who this might be right for
RSV InfectionAerosol Disease
Wake Forest University Health Sciences 7
Not applicableStudy completedNCT06325332
What this trial is testing

BEYFORTUS™ (Nirsevimab) Effectiveness Against Medically-Attended RSV Events in Infants (BEAR Study)

Who this might be right for
Respiratory Syncytial Virus
Sanofi Pasteur, a Sanofi Company 49,680
Early research (Phase 1)UnknownNCT04909021
What this trial is testing

Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seronegative Children 6-36 Months

Who this might be right for
Respiratory Syncytial Virus (RSV)
Meissa Vaccines, Inc. 63
Not applicableStudy completedNCT01349543
What this trial is testing

The Development of a Human Model of Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Virus InfectionsRespiratory Viral Infections
Imperial College London 58
Large-scale testing (Phase 3)WithdrawnNCT05229068
What this trial is testing

Safety, Reactogenicity and Immune Response of the Repeat Vaccination Against RSV When Given to Female Participants of 18-49 Years of Age During Their Subsequent Uncomplicated Pregnancy

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline
Early research (Phase 1)Study completedNCT01355016
What this trial is testing

A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of MDT-637 in Healthy Volunteers

Who this might be right for
Drug SafetyRespiratory Syncytial Virus Infections
MicroDose Therapeutx, Inc 48
Large-scale testing (Phase 3)Study completedNCT05590403
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50-59 Years of Age, Including Adults at Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease, Compared to Older Adults 60 Years of Age and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 1,544
Not applicableStudy completedNCT02622009
What this trial is testing

Viral Infections in BAL and Bronchial Biopsies of Stable COPD Patients

Who this might be right for
HRV and RSV Presence in the Lungs of Stable COPD Patients.
University of Athens 53
Next Page